PeriphaGen Inc Email Format

Pharmaceutical ManufacturingPennsylvania, United States2-10 Employees

PeriphaGen Inc is a biopharmaceutical company focused on peripheral nerve gene therapy, aiming to address difficult-to-treat neurological disorders by directly targeting neurons. Its lead program, PGN-503, seeks to protect against chemotherapy-induced peripheral neuropathy, with a pipeline also exploring gene-based approaches to block multiple pain pathways. The company operates in the pharmaceutical manufacturing space and pursues highly specific nervous system interventions that aim to reduce systemic adverse effects compared with broader treatments. Based in Pittsburgh, Pennsylvania, and with a small team, PeriphaGen positions itself as a specialty developer leveraging a targeted delivery approach to advance treatments for nerve-related conditions. A recent development notes a legal action involving a former lab partner, reflecting ongoing activity in its collaborative research landscape.

Get verified PeriphaGen Inc emails free

Company overview Employee directory